Suchergebnisse - "Bertrand, Marion"

PubPharm (37)

1

Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines : A Nationwide Self-Controlled Case Series Study

enthalten in: Neurology | 2023

von Le Vu, S. | Bertrand, M. | Botton, J. | +6

2

Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France

enthalten in: Annals of internal medicine | 2022

von Botton, J. | Jabagi, M. | Bertrand, M. | +7

3

Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule : A cohort study of 28 million people in France

enthalten in: The Lancet regional health. Europe | 2022

von Semenzato, L. | Botton, J. | Drouin, J. | +8

4

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines

enthalten in: Nature communications | 2022

von Le Vu, S. | Bertrand, M. | Jabagi, M. | +6

5

Association of Statins for Primary Prevention of Cardiovascular Diseases With Hospitalization for COVID-19 : A Nationwide Matched Population-Based Cohort Study

enthalten in: Journal of the American Heart Association | 2022

von Bouillon, K. | Baricault, B. | Semenzato, L. | +6

6

A modified self-controlled case series method for event-dependent exposures and high event-related mortality, with application to COVID-19 vaccine safety

enthalten in: Statistics in medicine | 2022

von Ghebremichael-Weldeselassie, Y. | Jabagi, M. | Botton, J. | +7

7

Risk of Myocardial Infarction, Stroke, or Death in New Users of Intravitreal Aflibercept Versus Ranibizumab : A Nationwide Cohort Study

enthalten in: Ophthalmology and therapy | 2022

von Billioti de Gage, S. | Bertrand, M. | Grimaldi, S. | +1

8

Intravitreal anti-VEGF use in France : a cross-sectional and longitudinal Nationwide observational study

enthalten in: Acta ophthalmologica | 2022

von Billioti de Gage, S. | Bertrand, M. | Grimaldi, S. | +1

9

Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines

enthalten in: Vaccine | 2022

von Botton, J. | Dray-Spira, R. | Baricault, B. | +5

10

Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting : cohort study

enthalten in: BMJ medicine | 2022

von Bouillon, K. | Baricault, B. | Botton, J. | +8